Manuscripts
October 4, 2021
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
The Journal for ImmunoTherapy of Cancer
Heilbroner SP et al
September 24, 2021
Survival in the real world: A national analysis of patients treated for early-stage breast cancer
JCO Oncology Practice
Gidwani R et al
June 1, 2021
Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database
JCO Clinical Cancer Informatics
Potter D et al
March 11, 2021
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations
JCO Oncology Practice
Alpert AB et al
February 21, 2021
Challenges and Opportunities to Developing a Frailty Index Using Electronic Health Record Data
Journal of Geriatric Oncology
Levit L et al
February 1, 2021
Impact of Broadening Trial Eligibility Criteria for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: Real-World Analysis of Select ASCO-Friends Recommendations
Cancer Clinical Research
Harvey D et al
November 17, 2020
Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer
Clinical Breast Cancer
Gilbert A et al
November 2, 2020
Improving Cancer Data Interoperability: The Promise of the mCODE (Minimal Common Oncology Data Elements) Initiative
JCO Clinical Cancer Informatics
Osterman T et al
October 2, 2020
Development of CancerLinQ, a health information learning platform from multiple Electronic Health Record (EHR) systems to support improved quality of care
JCO Clinical Cancer Informatics
Potter D et al
Abstracts
June 2, 2023
Site of metastasis (SoM) and its impact on clinical outcomes in 8 cancer cohorts
ASCO Annual Meeting 2023
George R et al
June 2, 2023
Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy
ASCO Annual Meeting 2023
Coutinho F et al
June 2, 2023
Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US)
ASCO Annual Meeting 2023
Kalinsky K et al
May 7, 2023
Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020
ISPOR 2023
Yang M et al
May 1, 2023
Association of clinical trial enrollment and mortality amongst patients with advanced prostate cancer
AUA Annual Meeting 2023
Pessoa RR et al
April 30, 2023
Variation of hormonal agent usage with postoperative radiation therapy: Results from a population based cohort of prostate cancer patients in community oncology practices
AUA Annual Meeting 2023
Pessoa RR et al
February 17, 2023
Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US
ASCO Genitourinary Cancers Symposium 2023
Kearney M et al
December 12, 2022
Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Cooper JD et al
December 11, 2022
Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with multiple myeloma (MM): An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Gibson SJ et al
